Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glycine site is a modulatory binding site located on the GluN1 subunit of the NMDA receptor, a subtype of ionotropic glutamate receptors. It is strychnine-insensitive and distinct from classical inhibitory glycine receptors. This site requires either glycine or D-serine as a co-agonist, along with glutamate, for NMDA receptor activation. The glycine/D-serine binding acts allosterically to facilitate NMDA receptor function, which is critical for synaptic plasticity, learning, memory formation, and neurodevelopment. Its dysfunction is implicated in neurological disorders.
Allosteric modulation of NMDA receptor activity; Co-agonist binding for channel opening
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine Site of N-methyl-D-aspartate (NMDA) Receptor (NMDA Receptor Glycine Site).